Tag: dermatology
#VisualAbstract: Local excision margins greater than 1 cm and receipt of radiotherapy are associated with improved overall survival in Merkel cell carcinoma
Teddy Guo -
Click to read the study in JAMA Dermatology.
#VisualAbstract: Increased risk of cutaneous squamous cell carcinomas among patients diagnosed wtih actinic keratosis
Teddy Guo -
Click to read the study in JAMA Dermatology.
Nivolumab plus ipilimumab is safe and effective for the treatment of advanced melanoma (CheckMate 218)
Teddy Guo -
Click to read the study in Melanoma Research.
#VisualAbstract: Higher metastatic lymph node burden is associated with worse overall survival in Merkel cell carcinoma
Teddy Guo -
Click to read the study in the Journal of the American Academy of Dermatology.
#VisualAbstract: Female sex may be associated with better overall and disease-specific survival in Merkel cell carcinoma
Teddy Guo -
Click to read the study in the Journal of the American Academy of Dermatology.
Bimekizumab shows better efficacy in treating severe plaque psoriasis than ustekinumab
Michael Pratte -
1. Bimekizumab showed higher efficacy in the treatment of severe plaque psoriasis than ustekinumab with patients showing greater proportion of PASI90 and IGA response.
2. The safety profile of Bimekizumab was overall mild and similar to current treatment option ustekinumab
Evidence Rating Level: 1 (Excellent)
Study Rundown: Plaque psoriasis is a chronic...
#VisualAbstract: Skin biopsy rates have disproportionately increased compared to cancer treatments between 1993-2016
Teddy Guo -
Click to read the study in the Journal of the American Academy of Dermatology.
Bimekizumab is tolerable and efficacious for patients with moderate to severe plaque psoriasis
Neel Mistry -
1. 91% of patients receiving bimekizumab 320 mg every 4 weeks achieved ≥ 90% improvement from baseline in the Psoriasis Area Severity Index (PASI90) compared to 1% receiving placebo.
2. After achieving PASI90 at week 16, bimekizumab response was maintained through week 56 in both dosing schedules (every 4 weeks...